Mechanisms and clinical implications of renal drug excretion*
- 1 January 2001
- journal article
- review article
- Published by Taylor & Francis Ltd in Drug Metabolism Reviews
- Vol. 33 (3-4), 299-351
- https://doi.org/10.1081/dmr-120000654
Abstract
The body defends itself against potentially harmful compounds like drugs, toxic compounds, and their metabolites by elimination, in which the kidney plays an important role. Renal clearance is used to determine renal elimination mechanisms of a drug, which is the result of glomerular filtration, active tubular secretion and reabsorption. The renal proximal tubule is the primary site of carrier-mediated transport from blood to urine. Renal secretory mechanisms exists for, anionic compounds and organic cations. Both systems comprises several transport proteins, and knowledge of the molecular identity of these transporters and their substrate specificity has increased considerably in the past decade. Due to overlapping specificities of the transport proteins, drug interactions at the level of tubular secretion is an event that may occur in clinical situation. This review describes the different processes that determine renal drug handling, the techniques that have been developed to attain more insight in the various aspects of drug excretion, the functional characteristics of the individual transport proteins, and finally the implications of drug interactions in a clinical perspective.Keywords
This publication has 239 references indexed in Scilit:
- Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and AdefovirClinical Pharmacokinetics, 1999
- Direct Evidence for Peptide Transporter (PepT1)-Mediated Uptake of a Nonpeptide Prodrug, ValacyclovirBiochemical and Biophysical Research Communications, 1998
- cDNA Cloning and Functional Expression of a Novel Rat Kidney Organic Cation Transporter, OCT2Biochemical and Biophysical Research Communications, 1996
- Pharmacological considerations in the modulation of multidrug resistanceEuropean Journal of Cancer, 1996
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.JCI Insight, 1995
- Cimetidine improves the reliability of creatinine as a marker of glomerular filtrationKidney International, 1991
- Moment analysis of drug disposition in kidney. VI: Assessment ofin vivo transmembrane transport ofp-aminohippurate in tubular epitheliumJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Amphotericin B NephrotoxicityDrug Safety, 1990
- The Effect of Probenecid on Nafcillin DispositionThe Journal of Clinical Pharmacology, 1982
- Enzymes, drugs and transport phenomenaProtoplasma, 1967